Stocks and Investing Stocks and Investing
Wed, March 15, 2023
Tue, March 14, 2023

Robert Burns Reiterated (VIRX) at Strong Buy and Held Target at $35 on, Mar 14th, 2023


Published on 2024-10-28 02:15:51 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Reiterated "Viracta Therapeutics, Inc." (VIRX) at Strong Buy and Held Target at $35 on, Mar 14th, 2023.

Robert, nor any peers, have made any analyst calls on VIRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources